{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:35:55Z","timestamp":1777581355428,"version":"3.51.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Clinical Discipline, the Fundamental Research Funds for the young teacher training program of Sun Yat-sen University","award":["18ykpy02"],"award-info":[{"award-number":["18ykpy02"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province of China","award":["A2016198"],"award-info":[{"award-number":["A2016198"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province of China","award":["5010"],"award-info":[{"award-number":["5010"]}]},{"name":"Clinical Research Programme\u2019 of Sun Yat-sen University","award":["2010012"],"award-info":[{"award-number":["2010012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The tumor immune microenvironment is one of the most important prognostic factors in liver metastasis from colorectal cancer. Low-dose cyclophosphamide (CTX) is widely believed to be involved in the modulation of the immune system. However, the underlying mechanism of low-dose CTX remains unknown. This study aimed to investigate the antitumor immunity of low-dose CTX in the treatment of colon-cancer liver metastasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Thirty mice were randomly divided into five groups. After liver metastasis was established in colon-cancer models, mice in the treatment groups were injected with low-dose CTX (20\u2009mg\/kg) at different time points. Liver and spleen tissues were examined for T-cell markers via flow cytometry. Interleukin (IL)-10 and transforming growth factor (TGF)-\u03b21 expression levels in liver tissues were analysed by immunohistochemistry. Serum interferon (IFN)-\u03b3 and IL-10 levels were detected by enzyme-linked immunosorbent assay. An additional 20 mice were randomly allocated into two groups and the survival times were recorded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The expression levels of CD4+ T cells, CD8+ T cells, and IFN-\u03b3 were down-regulated, whereas those of IL-10 and TGF-\u03b21 were up-regulated in liver metastasis from colon cancer in mice. Furthermore, the local and systemic microenvironments of the liver were altered, which led to reduced antitumor immune responses and subsequently liver metastasis. However, treatment with low-dose CTX reversed these effects. The survival times of mice treated with low-dose CTX were significantly longer than those of the other groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Low-dose CTX exerts its antitumor activity by changing the systemic and local immune microenvironments and enhancing immune regulation in mice. CTX could be used as a drug to prevent and treat liver metastasis from colon cancer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/gastro\/goz060","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T20:09:53Z","timestamp":1574107793000},"page":"56-65","source":"Crossref","is-referenced-by-count":26,"title":["Antitumor immunity of low-dose cyclophosphamide: changes in T cells and cytokines TGF-beta and IL-10 in mice with colon-cancer liver metastasis"],"prefix":"10.1093","volume":"8","author":[{"given":"Xiao-Ming","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Rong","family":"Zhang","sequence":"first","affiliation":[{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Anesthesiology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Tao","family":"Lin","sequence":"first","affiliation":[{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Gastrointestinal Endoscopy, Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Yan","family":"Zhu","sequence":"first","affiliation":[{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Pharmacy, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Feng","family":"Zou","sequence":"first","affiliation":[{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jian","family":"Wu","sequence":"first","affiliation":[{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Sheng","family":"He","sequence":"first","affiliation":[{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Wen","family":"He","sequence":"first","affiliation":[{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Le","family":"Wan","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Lan","sequence":"first","affiliation":[{"name":"Guangdong Institute of Gastroenterology; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"},{"name":"Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"key":"2020022107293297300_goz060-B1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clcc.2013.04.002","article-title":"Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases","volume":"12","author":"Brandi","year":"2013","journal-title":"Clin Colorectal Cancer"},{"key":"2020022107293297300_goz060-B2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jss.2013.04.065","article-title":"Predicting metachronous liver metastasis from colorectal cancer using serum proteomic fingerprinting","volume":"184","author":"Zhu","year":"2013","journal-title":"J Surg Res"},{"key":"2020022107293297300_goz060-B3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jamcollsurg.2012.12.029","article-title":"Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis","volume":"216","author":"Mayo","year":"2013","journal-title":"J Am Coll Surg"},{"key":"2020022107293297300_goz060-B4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0305-7372(10)00036-8","article-title":"The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer","volume":"36(Suppl 1)","author":"Bouche","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"2020022107293297300_goz060-B5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"key":"2020022107293297300_goz060-B6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2009.09.067","article-title":"Immunotherapy of cancer","volume":"625","author":"Borghaei","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"2020022107293297300_goz060-B7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gde.2007.12.007","article-title":"Immune surveillance: a balance between protumor and antitumor immunity","volume":"18","author":"Ostrand-Rosenberg","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"2020022107293297300_goz060-B8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcancer.2005.11.004","article-title":"Functional control of regulatory T cells and cancer immunotherapy","volume":"16","author":"Wang","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"2020022107293297300_goz060-B9","article-title":"Regulatory T cells and human disease","volume":"89195","author":"Cools","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"2020022107293297300_goz060-B10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41416-018-0076-z","article-title":"Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma","volume":"118","author":"Orecchioni","year":"2018","journal-title":"Br J Cancer"},{"key":"2020022107293297300_goz060-B11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/CJI.0b013e31826f79a6","article-title":"Improvement of antitumor effect of intratumoral injection of immature dendritic cells into irradiated tumor by cyclophosphamide in mouse colon cancer model","volume":"35","author":"Son","year":"2012","journal-title":"J Immunother"},{"key":"2020022107293297300_goz060-B12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellimm.2016.08.006","article-title":"Improvement of anti-tumor immunity of fibroblast activation protein \u03b1 based vaccines by combination with cyclophosphamide in a murine model of breast cancer","volume":"310","author":"Xia","year":"2016","journal-title":"Cell Immunol"},{"key":"2020022107293297300_goz060-B13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.humimm.2011.12.020","article-title":"Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells","volume":"73","author":"Traverso","year":"2012","journal-title":"Hum Immunol"},{"key":"2020022107293297300_goz060-B14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00281-011-0245-0","article-title":"Immunomodulatory effects of cyclophosphamide and implementations for vaccine design","volume":"33","author":"Sistigu","year":"2011","journal-title":"Semin Immunopathol"},{"key":"2020022107293297300_goz060-B15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00262-007-0305-4","article-title":"Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine","volume":"56","author":"Liu","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"2020022107293297300_goz060-B16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/1078-0432.CCR-06-1209","article-title":"Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration","volume":"13","author":"Bracci","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2020022107293297300_goz060-B17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1567-5769(00)00028-X","article-title":"Down regulation of T-cell-derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal lymphoproliferative response","volume":"1","author":"Matar","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"2020022107293297300_goz060-B18","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1158\/0008-5472.CAN-11-3912","article-title":"Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective","volume":"72","author":"Le","year":"2012","journal-title":"Cancer Res"},{"key":"2020022107293297300_goz060-B19","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1158\/1078-0432.CCR-17-0895","article-title":"Low-dose cyclophosphamide induces antitumor T-cell responses, which associate with survival in metastatic colorectal cancer","volume":"23","author":"Scurr","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2020022107293297300_goz060-B20","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","article-title":"Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide","volume":"105","author":"Lutsiak","year":"2005","journal-title":"Blood"},{"key":"2020022107293297300_goz060-B21","doi-asserted-by":"crossref","first-page":"e172579.","DOI":"10.1001\/jamaoncol.2017.2579","article-title":"Effect of modified vaccinia Ankara-5T4 and low-dose cyclophosphamide on antitumor immunity in metastatic colorectal cancer: a randomized clinical trial","volume":"3","author":"Scurr","year":"2017","journal-title":"JAMA Oncol"},{"key":"2020022107293297300_goz060-B22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s11605-013-2194-5","article-title":"Changes of T cells and cytokines TGF-beta1 and IL-10 in mice during liver metastasis of colon carcinoma: implications for liver anti-tumor immunity","volume":"17","author":"Huang","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"2020022107293297300_goz060-B23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jnci\/djx123","article-title":"Comprehensive intrametastatic immune quantification and major impact of immunoscore on survival","volume":"110","author":"Mlecnik","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"2020022107293297300_goz060-B24","doi-asserted-by":"crossref","first-page":"e1470729.","DOI":"10.1080\/2162402X.2018.1470729","article-title":"Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer","volume":"7","author":"Grossman","year":"2018","journal-title":"Oncoimmunology"},{"key":"2020022107293297300_goz060-B25","article-title":"Macrophages in colorectal cancer liver metastases","author":"Cortese","year":"7  2019","journal-title":"Cancers (Basel)"},{"key":"2020022107293297300_goz060-B26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jcmgh.2017.01.006","article-title":"Colorectal cancer liver metastasis: evolving paradigms and future directions","volume":"3","author":"Zarour","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2020022107293297300_goz060-B27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.187.5.693","article-title":"Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors","volume":"187","author":"Ossendorp","year":"1998","journal-title":"J Exp Med"},{"key":"2020022107293297300_goz060-B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2007.00869.x","article-title":"Th2-mediated anti-tumour immunity: friend or foe?","volume":"70","author":"Ellyard","year":"2007","journal-title":"Tissue Antigens"},{"key":"2020022107293297300_goz060-B29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2020022107293297300_goz060-B30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/clim.2001.5163","article-title":"Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery","volume":"102","author":"Galizia","year":"2002","journal-title":"Clin Immunol"},{"key":"2020022107293297300_goz060-B31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2009.11.008","article-title":"Transforming growth factor beta (TGF-beta) and inflammation in cancer","volume":"21","author":"Bierie","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"2020022107293297300_goz060-B32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol"},{"key":"2020022107293297300_goz060-B33","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pag\u00e8s","year":"2005","journal-title":"N Engl J Med"},{"key":"2020022107293297300_goz060-B34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4614-1445-2_6","article-title":"Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs","volume":"734","author":"Bellovin","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"2020022107293297300_goz060-B35","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"JCO"},{"key":"2020022107293297300_goz060-B36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(09)60404-9","article-title":"Use of tumour-responsive T cells as cancer treatment","volume":"373","author":"Disis","year":"2009","journal-title":"Lancet"},{"key":"2020022107293297300_goz060-B37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1172\/JCI21148","article-title":"Immune system versus tumor: shifting the balance in favor of DCs and effective immunity","volume":"113","author":"Kaufman","year":"2004","journal-title":"J Clin Invest"},{"key":"2020022107293297300_goz060-B38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00109-003-0430-2","article-title":"B7-H1 pathway and its role in the evasion of tumor immunity","volume":"81","author":"Dong","year":"2003","journal-title":"J Mol Med"},{"key":"2020022107293297300_goz060-B39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","article-title":"B7-H4, a molecule of the B7 family, negatively regulates T cell immunity","volume":"18","author":"Sica","year":"2003","journal-title":"Immunity"},{"key":"2020022107293297300_goz060-B40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.coi.2006.01.004","article-title":"The role of stroma in immune recognition and destruction of well-established solid tumors","volume":"18","author":"Yu","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"2020022107293297300_goz060-B41","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI31202","article-title":"Tregs and rethinking cancer immunotherapy","volume":"117","author":"Curiel","year":"2007","journal-title":"J Clin Invest"},{"key":"2020022107293297300_goz060-B42","first-page":"1002","article-title":"Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy","volume":"8","author":"Schabowsky","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"2020022107293297300_goz060-B43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/eji.200324181","article-title":"CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative","volume":"34","author":"Ghiringhelli","year":"2004","journal-title":"Eur J Immunol"},{"key":"2020022107293297300_goz060-B44","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1158\/0008-5472.CAN-10-0283","article-title":"Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res"},{"key":"2020022107293297300_goz060-B45","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood.V95.6.2024","article-title":"Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer","volume":"95","author":"Schiavoni","year":"2000","journal-title":"Blood"},{"key":"2020022107293297300_goz060-B46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00262-001-0237-3","article-title":"Th2\/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model","volume":"50","author":"Matar","year":"2002","journal-title":"Cancer Immunol Immunother"},{"key":"2020022107293297300_goz060-B47","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1158\/0008-5472.CAN-10-1259","article-title":"Cyclophosphamide induces differentiation of Th17 cells in cancer patients","volume":"71","author":"Viaud","year":"2011","journal-title":"Cancer Res"},{"key":"2020022107293297300_goz060-B48","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood-2009-06-224246","article-title":"Th17 cells in ovarian cancer","volume":"114","author":"Munn","year":"2009","journal-title":"Blood"},{"key":"2020022107293297300_goz060-B49","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1002\/eji.201444879","article-title":"Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis","volume":"44","author":"Dimeloe","year":"2014","journal-title":"Eur J Immunol"},{"key":"2020022107293297300_goz060-B50","doi-asserted-by":"crossref","first-page":"e83384.","DOI":"10.1371\/journal.pone.0083384","article-title":"Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response","volume":"8","author":"Heylmann","year":"2013","journal-title":"PLoS One"}],"container-title":["Gastroenterology Report"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/8\/1\/56\/32538697\/goz060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/8\/1\/56\/32538697\/goz060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T12:30:11Z","timestamp":1582288211000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/gastro\/article\/8\/1\/56\/5637323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12,5]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/gastro\/goz060","relation":{},"ISSN":["2052-0034"],"issn-type":[{"value":"2052-0034","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2019,12,5]]}}}